You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -138.2% | -2.5% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -22.8 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 30.4 | 9.6 |
| Price / Book value | 21.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 631.2% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-05-31 | 0.21 | -5.32 | -9.84p | -14.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-05-31 | 0.24 | -6.34 | -11.41p | -11.1 | 0.0 | n/a | n/a | 0.0% |
| 2019-05-31 | 0.17 | -8.55 | -12.97p | -7.1 | 0.0 | n/a | n/a | 0.0% |
| 2020-05-31 | 0.51 | -9.78 | -13.36p | -8.3 | 0.0 | n/a | n/a | 0.0% |
| 2021-05-31 | 3.72 | -5.70 | -7.17p | -29.1 | 0.0 | n/a | n/a | 0.0% |
| Oncimmune inks deal with global pharma firm Sharecast News | 20 Sep |
|---|---|
| Oncimmune upbeat on three-year lung cancer test study Sharecast News | 23 Aug |
| Oncimmune inks research deal with Dana-Farber Cancer Institute Sharecast News | 23 Jul |
| Second Price Monitoring Extn | 26-Nov-21 16:41 |
|---|---|
| Price Monitoring Extension | 26-Nov-21 16:36 |
| Results of Annual General Meeting | 26-Nov-21 10:36 |
| Notice of AGM and posting of Annual Report | 03-Nov-21 07:00 |
| Full year results and progress update | 02-Nov-21 07:00 |